WallStreetZenWallStreetZen

NASDAQ: RAPT
Rapt Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

RAPT past revenue growth

How has RAPT's revenue growth performed historically?
Company
-100%
Industry
151.46%
Market
17.61%
RAPT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RAPT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

RAPT earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$116.8M
Current Profit Margin
0%

RAPT Return on Equity

Current Company
-63.1%
Current Industry
-63.5%
Current Market
188%
RAPT's Return on Equity (-63.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when RAPT announces earnings.

RAPT Return on Assets

Current Company
-55.5%
Current Industry
2.9%
RAPT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

RAPT Return on Capital Employed

Current Company
-77.1%
Current Industry
19.5%
RAPT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RAPT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
RAPT$0.00-$113.25M-$116.80M-100.00%N/A
BDTX$0.00-$82.01M-$82.44MN/AN/A
ENTA$73.62M-$124.91M-$138.24M-20.94%N/A
IVVD$0.00-$196.62M-$198.64MN/AN/A
ERAS$0.00-$121.31M-$125.04MN/AN/A
View Top Biotech Stocks

RAPT earnings dates

Next earnings date
May 9, 2024

Rapt Therapeutics Earnings & Revenue FAQ

What were RAPT's earnings last quarter?

On Invalid Date, Rapt Therapeutics (NASDAQ: RAPT) reported Q4 2023 earnings per share (EPS) of -$0.81, up 24.62% year over year. Total Rapt Therapeutics earnings for the quarter were -$30.88 million. In the same quarter last year, Rapt Therapeutics's earnings per share (EPS) was -$0.65.

If you're new to stock investing, here's how to buy Rapt Therapeutics stock.

What was RAPT's earnings growth in the past year?

As of Q2 2024, Rapt Therapeutics's earnings has grown year over year. Rapt Therapeutics's earnings in the past year totalled -$116.80 million.

What is RAPT's earnings date?

Rapt Therapeutics's earnings date is Invalid Date. Add RAPT to your watchlist to be reminded of RAPT's next earnings announcement.

What was RAPT's revenue last quarter?

On Invalid Date, Rapt Therapeutics (NASDAQ: RAPT) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Rapt Therapeutics's revenue was $0.00.

What was RAPT's revenue growth in the past year?

As of Q2 2024, Rapt Therapeutics's revenue has grown -100% year over year. This is 251.46 percentage points lower than the US Biotechnology industry revenue growth rate of 151.46%. Rapt Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.